U.S. Regional Biocontainment Lab to Begin Testing of Brilacidin Against Coronavirus (COVID-19) Next Week


You May Also Like

Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer

Industry veteran, Dr. Hutchins, to advance Heat’s platform technologies and pursue immunotherapy combinationsFormer CSO ...

Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period

Transaction expands Novartis Oncology neuroendocrine tumor (NET) treatment portfolio and adds radiopharmaceutical technology platform Lutathera® ...